page_title

Integrative Cardiovascular Conference Schedule


Click on presenter name link to view their bio. Schedule is tentative and subject to change. Download the schedule.

Saturday, May 18, 2013


7:45 – 8:15 a.m.

Sign-in and registration

8:15 – 9:45 a.m.
Kasra Pournadeali, ND

 

Non Drug Treatment of Hypertension: Literature Updates & What Works

Haven’t had time to review the literature for the latest non-drug treatments for Hypertension? Wanting to know which newly-promoted approaches are evidenced and which are not? Dr. Pournadeali has been the faculty for Cardiology at Bastyr for over 10 years, and brings nearly 20 years of interventional and naturopathic cardiology experience in the hospital and private practice setting. Attendees of this talk can expect well-referenced information and clinical pearls that can be applied immediately.

Learning Objectives:

  • The attendee will identify non-drug treatment options for hypertension based on recent publications.
  • The attendee will be able to identify non-drug treatment options for hypertension, based on the patient’s concomitant conditions.
  • Using a case-based model, the attendee will be able to choose effective treatment options for a patient with hypertension
     

10:00 – 11:30 a.m.
Beverly Yates, ND

 

Cardiovascular Disorders in Women

Important issues that affect treatment outcomes for women with CV disorders will be covered in this presentation. The reasons for missed diagnosis of CV diseases in women are revealed, along with the impact this has on treatment outcomes. Case studies offer treatment plan strategies, including stand-alone natural therapies or integrative medical approaches for the successful treatment of female patients with CV disorders. Special considerations discussed for specific co-morbidities, e.g. dyslipidemia, morbid obesity, Type 2 diabetes, hypertension and common sequelae of pharmaceuticals used for CV interventions.

Learning Objectives:

  • Differential diagnosis of CV symptoms in women
  • Awareness of disparities in diagnosis and treatment of women
  • Using Systems Approach® to address “symptoms”
  • Case Studies including:
    • Atrial Tachycardia
    • Mitral Valve Prolapse
    • Cardiomyopathy
    • Palpitations
    • Ectopic Heartbeats
    • Atrial Fibrillation
  • Co-morbidities: hypertension, dyslipidemia, morbid obesity, Type 2 diabetes

11:30 a.m.– 12:30 p.m.

Lunch break

12:30 – 2:00 p.m.
Steve Parcell, ND

 

Advanced Cardiovascular Risk Assessment Using Imaging and Novel Biomarkers

Dr. Parcell will introduce this talk by explaining why the standard of care is not adequate in the United States for heart attack prevention. He will review the important biomarkers and imaging technologies that have become available in recent years. Then Dr. Parcell will explain how these results can be combined to create a more accurate assessment of a patient’s real risk.  He will then discuss how to use these test results to guide the selection of treatments and gain compliance with treatment. Most importantly Dr. Parcell will provide instruction for how to prevent heart attacks and how to stabilize or reverse arterial plaque.

Learning objectives:

  • Understand why the current standard of care is not adequate for many patients in the United States and why integrative medicine clinicians are uniquely positioned to lower the incidence of cardiovascular events.
  • Understand how to interpret novel biomarkers to individualize care and discuss them with the patient.
  • Learn how to properly follow up with these patients and ensure compliance.
  • Understand when to order heart scans and carotid studies and how to interpret and use them to improve outcomes.
  • Learn how to integrate naturopathic workup and treatment with conventional medicine.

 

2:15 – 3:45 p.m.
Peter Banitt, MD

 

Coronary Artery Disease: What Every Physician Needs to Know

Coronary artery disease (CAD) is an extremely important medical condition as heart disease is the leading cause of death in the United States.  Many factors contribute to the development of coronary artery disease, and there are many treatment options for patients with this diagnosis.

Cardiologist Peter Banitt will review etiology, risk factors and pathophysiology of CAD, and offer practical advice for practicing primary care providers. He will explain which patients will benefit from statin drugs. He will discuss which patients need a stent versus who could be treated with only medications.  Moreover, Dr. Banitt will explain the likelihood that your patient will have a cardiac event in the next 10 years.
 

4:00 – 5:30 p.m.
Ahvie Herskowitz, MD

Arrhythmias, Valvular Disorders and Cardiomyopathy

As our patients’ ability to cohabitate with stress, nutritional and environmental challenges coronary and non-coronary cardiovascular disease have exploded in incidence. Dr. Herskowitz will explore different causes for this increase and pathophysiology and treatment paradigms both western and alternative for atrial fibrillation, valvular disorders, cardiomyopathy and cardiac infections.

Sunday, May 19, 2013


 7:45 – 8:15 a.m.

Sign-in and registration

8:15 – 9:45 a.m.
Ryan Bradley, ND, MPH

 

Endothelial Dysfunction: A Shared Mechanism of Dysfunction in Metabolic and Coronary Diseases

This presentation will update attendees on the concept of endothelial dysfunction; its pathophysiology; its importance in disease risk beyond cardiovascular disease; and integrative treatment approaches.  Endothelial dysfunction is a common, cumulative pathophysiological mechanism that occurs secondary to dietary and environmental exposures, and occurs in nearly every vascular bed. This presentation will teach attendees about the importance of improving endothelial cell function to promote health beyond just cardiovascular disease. Recent evidence implicates endothelial dysfunction (ED) in the progression of metabolic disease, asthma, chronic kidney disease, sexual function, autoimmune disease, neurodegenerative disease, and coronary artery disease. 

10:00 – 11:30 a.m.
Kasra Pournadeali, ND

 

Naturopathic Use of Antihypertensives: When Non-Drug Options Fail

Cardiology Expert, Dr. Kasra Pournadeali returns to review “naturopathic” application of antihypertensive drugs, and JNC guidelines for their use.  A must-attend presentation for when you are considering a prescription medication for patients needing more than lifestyle change, therapeutic nutrition, or plant medicines.  Don’t miss it!

Learning Objectives:

  • The attendee will be able to choose antihypertensives based on most recent guidelines.
  • The attendee will be able to choose antihypertensives based on the patient’s other diseases.
  • The attendee will be able to choose antihypertensives based on a whole person perspective.

11:30 a.m.– 12:30 p.m.

Lunch break

12:30 – 2:00 p.m.
Marty Milner, ND

 

New Horizons in Cardiovascular Exercise Rehabilitation

Enjoy a 90 minute foray into the critical management of therapeutic exercise in the cardiovascular patient.  Exercise in this population is often challenging and complicated by the combination of poly pharmacy and comorbidities which may alter exercise outcomes.  The discussion will include general cardiac rehabilitation guidelines followed by training in the use of:

  • aerobic exercise tolerance testing
  • aerobic exercise prescription guidelines
  • oxygen multistep therapy
  • nutrient packets in advance of exercise to enhance performance
  • interval training

Dr. Milner has spent his entire 30 years of clinical practice refining these exercise protocols and enjoys sharing his perspectives.

2:15 – 3:45 p.m.
Jeremy Mikolai, ND

Integrative Management of Heart Failure

Dr. Mikolai will cover the evidence-informed use of complementary and alternative (CAM) therapeutics in the management several types of heart failure.  Systolic failure, diastolic failure, ischemic cardiomyopathy, atrial fibrillation and several types of valvular disease will all be addressed as potential causes of heart failure; the indications, applications, and contraindications for common CAM therapies in each of these circumstances will be discussed.  The importance of potential contraindications or conflicts between CAM and conventional management will be emphasized.  


Through participation in the lecture attendees will be able to:

  • Understand and discuss the differing types of heart failure commonly encountered in clinical practice
  • Discuss the typical conventional management of various types of heart failure including common cardiac drugs and devices used in the treatment of heart failure
  • Discuss and apply evidence-informed complementary and alternative (CAM) medicine to the treatment of common types of heart failure and its integration with conventional management strategies with special considerations toward safety and potential contraindications

4:00 – 5:30 p.m.
Peter Jones, PhD

Plant Sterols and Heart Health

Return to the information page